Head of Pharmaceutical R&D
Nanexa AB
Uppsala, Uppsala Lan, Sweden
Dr. Hellrup received his PhD in pharmaceutical sciences in 2016 from Uppsala University, Sweden. He joined Nanexa AB, Sweden as Formulation scientist in 2016. Today, Dr. Hellrup serves as Head of Pharmaceutical R&D at Nanexa. He is one of the key developers of the PharmaShell® technology, and is named as an inventor on several patent applications.
Disclosure information not submitted.
PharmaShell: Enabling High-Load, Long-Acting Injectables
Tuesday, July 15, 2025
5:45 PM - 5:50 PM EDT
Advancing Long-Acting Injectables: LAI Breakthroughs and the Science of PharmaShell
Thursday, July 17, 2025
9:00 AM - 9:30 AM EDT
